WMT

112.46

+0.63%↑

COST

867.76

-0.65%↓

TGT

98.06

-1.43%↓

KR

62.64

-0.98%↓

DG.US

137.38

-0.26%↓

WMT

112.46

+0.63%↑

COST

867.76

-0.65%↓

TGT

98.06

-1.43%↓

KR

62.64

-0.98%↓

DG.US

137.38

-0.26%↓

WMT

112.46

+0.63%↑

COST

867.76

-0.65%↓

TGT

98.06

-1.43%↓

KR

62.64

-0.98%↓

DG.US

137.38

-0.26%↓

WMT

112.46

+0.63%↑

COST

867.76

-0.65%↓

TGT

98.06

-1.43%↓

KR

62.64

-0.98%↓

DG.US

137.38

-0.26%↓

WMT

112.46

+0.63%↑

COST

867.76

-0.65%↓

TGT

98.06

-1.43%↓

KR

62.64

-0.98%↓

DG.US

137.38

-0.26%↓

Search

Afya Ltd (Class A)

Cerrado

SectorConsumo defensivo

14.86 -0.47

Resumen

Variación precio

24h

Actual

Mínimo

14.57

Máximo

14.93

Métricas clave

By Trading Economics

Ingresos

-13M

181M

Ventas

9.1M

929M

P/B

Media del Sector

10.285

28.655

Rentabilidad por dividendo

1.59

Margen de beneficios

19.455

EBITDA

-28M

397M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+32.11% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.59%

3.59%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

30M

1.3B

Apertura anterior

15.33

Cierre anterior

14.86

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

67 / 147 Clasificación en Consumer defensive

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Afya Ltd (Class A) Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 dic 2025, 22:03 UTC

Principales Movimientos del Mercado

Mining Stocks Slip Near the End of Stellar Year

29 dic 2025, 15:57 UTC

Principales Movimientos del Mercado

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dic 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Decline; Yen in Focus -- Market Talk

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Operate From Singapore

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dic 2025, 23:37 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Integrate Manus Service Into Products

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dic 2025, 23:35 UTC

Adquisiciones, fusiones, absorciones

Manus to Join Meta Platforms

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Raise Values Kraken at US$8.65 Billion

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin's Kraken Stake to Remain at 22.7%

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin: Additional Interest Offsets Dilution From Raise

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dic 2025, 21:27 UTC

Adquisiciones, fusiones, absorciones

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dic 2025, 20:22 UTC

Charlas de Mercado

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dic 2025, 20:02 UTC

Adquisiciones, fusiones, absorciones

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dic 2025, 17:36 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Comparación entre iguales

Cambio de precio

Afya Ltd (Class A) previsión

Precio Objetivo

By TipRanks

32.11% repunte

Estimación a 12 Meses

Media 19.75 USD  32.11%

Máximo 22 USD

Mínimo 17.5 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Afya Ltd (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

18.968 / 19.56Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

67 / 147 Clasificación en Consumo defensivo

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat